Clinical Trial

TCM Daoyin Therapy in Individuals At-risk for COPD

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
Chronic obstructive pulmonary disease (COPD) is a common, preventable and treatable disease. The aim of prospective randomized study is to evaluate the effects of TCM Daoyin training on Individuals at-risk for COPD.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-07-04; most recent amendment 2026-04-23.
Status change: Recruiting → Active, Not Recruiting 2025-03-29
Trial Details
NCT Number NCT05940480
Lead Sponsor Shanghai University of Traditional Chinese Medicine
Collaborators: Changzheng Community Health Service Center of Putuo District, Shanghai
Conditions Chronic Obstructive Pulmonary Disease, Lung Diseases, Obstructive
Enrollment 60 participants
Start Date 2023-01-03
Primary Completion 2027-06-30 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-04-29